Clinical efficacy and palatability of pradofloxacin 2.5% oral suspension for the treatment of bacterial lower urinary tract infections in cats

Journal of Veterinary Internal Medicine

Volumn 21, Issue 5, 2007, Pages 990-995

  Litster, Annette ^a   Moss, Susan ^a   Honnery, Mary ^a   Rees, Bob ^b   Edingloh, Markus ^c   Trott, Darren ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Australia Ltd   (Australia)

^c BAYER AG   (Germany)

Author keywords

Bacterial cystitis; Cats; Fluoroquinolone

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; DOXYCYCLINE; PRADOFLOXACIN; QUINOLONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL; ANIMAL DISEASE; ARTICLE; BACTERIAL INFECTION; CAT; CAT DISEASE; CLINICAL TRIAL; DRUG EFFECT; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; GRAM POSITIVE COCCI; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; NONPARAMETRIC TEST; QUESTIONNAIRE; TASTE; URINARY TRACT INFECTION; URINE;

AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANIMALS; ANTI-BACTERIAL AGENTS; CAT DISEASES; CATS; DOXYCYCLINE; FEMALE; FLUOROQUINOLONES; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; GRAM-POSITIVE COCCI; MALE; MICROBIAL SENSITIVITY TESTS; QUESTIONNAIRES; STATISTICS, NONPARAMETRIC; TASTE; URINARY TRACT INFECTIONS;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 34848837059     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2007)21[990:CEAPOP]2.0.CO;2     Document Type: Article

References (25)

1. Buffington C, Westrop J, Chew D, et al. Risk factors associated with clinical signs of lower urinary tract disease in indoor-housed cats. J Am Vet Med Assoc 2006;228:722-725.
2. Bartges J, Barsanti J. 2000 Bacterial urinary tract infection in cats. In: Bonagura JD, ed. Current Veterinary Therapy XIII. Philadelphia, PA: WB Saunders; 2001:880-882.
3. Blanco L, Bartges J. Understanding and eradicating bacterial urinary tract infections. Vet Med 2001;96:776-790.
4. Bartges J. Bacterial urinary tract infections-simple and complicated. Vet Med 2005;100:224-230.
5. Kruger J, Osborne C, Goyal SM, et al. Clinical evaluation of cats with lower urinary tract disease. J Am Vet Med Assoc 1991;199:211-216.
6. Buffington C, Chew D, Kendall MS, et al. Clinical evaluation of cats with nonobstructive urinary tract diseases. J Am Vet Med Assoc 1997;210:46-50.
7. Lekcharoensuk C, Osborne C, Lulich J. Epidemiologic study of risk factors for lower urinary tract diseases in cats. J Am Vet Med Assoc 2001;218:1429-1435.
8. Gunn-Moore D. Feline lower urinary tract disease. J Feline Med Surg. 2003;5(2):133-138.
9. Körber B, Luhmer E, Wetzstein H-G, et al. Bactericidal mechanisms of pradofloxacin, a novel 8-cyanofluoroquinolone. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology. San Diego, CA; 2002.
10. Litster A, Moss SM, Honnery M, et al. Prevalence of bacterial species in cats with clinical signs of lower urinary tract disease: Recognition of Staphylococcus felis as a possible feline urinary tract pathogen. Vet Micro. 2007;121:182-188.
11. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard-2nd Ed. Approved Standard M31-A2. Wayne, PA: NCCLS; 2002a.
12. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing: Twelfth Informational Supplement M100-S12. Wayne, PA: NCCLS; 2002b.
13. Gregory C, Vasseur P. Long-term examination of cats with perineal urethrostomy. Vet Surg. 1983;12:210-212.
14. Barsanti J, Blue J, Edmunds J. Urinary tract infection due to indwelling bladder catheters in dogs and cats. J Am Vet Med Assoc. 1985;187:384-388.
15. Davidson A, Ling G, Stevens F, et al. Urinary tract infection in cats: A retrospective study 1977-1989. California Vet. 1992;46:32-34.
16. Lees G. Bacterial urinary tract infections. Vet Clin North Am Small Anim Pract 1996;26:297-304.
17. Senior D. Management of difficult urinary tract infections. In: Bonagura JD, ed. Current Veterinary Therapy XIII. Philadelphia, PA: WB Saunders; 2000:883-886.
18. Garrison J, Hooton TM. Fluoroquinolones in the treatment of acute uncomplicated urinary tract infections in adult women. Expert Opin Pharmacother. 2001;2:1227-1237.
19. Warren JW, Abrutyn E, Hebel JR. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis. 1999;29:745-758.
20. Sidjabat HE, Townsend KM, Hanson ND, et al. Identification of bla(CMY-7) and associated plasmid-mediated resistance genes in multidrug-resistant Escherichia coli isolated from dogs at a veterinary teaching hospital in Australia. J Antimicrob Chemother. 2006;57:840-848.
21. Sidjabat HE, Townsend KM, Lorentzen M, et al. Emergence and spread of two distinct clonal groups of multidrug-resistant Escherichia coli in a veterinary teaching hospital in Australia. J Med Microbiol. 2006;55:1125-1134.
22. Wetzstein HG. Comparative mutant prevention concentrations of pradofloxacin and other veterinary fluoroquinolones indicate differing potentials in preventing selection of resistance. Antimicrob Agents Chemother. 2005;49:4166-4173.
23. Oyamada Y, Ito H, Inoue M, et al. Topoisomerase mutations and efflux are associated with fluoroquinolone resistance in Enterococcus faecalis. J Med Microbiol. 2006;55: 1395-1401.
24. Litster A, Moss S, Honnery M, et al. Clinical efficacy of pradofloxacin oral suspension for the treatment of urinary tract infections in cats in Australia. First International Veraflox® Symposium. Proceedings. Berlin, Germany; 2006.
25. Thombre AG. Oral delivery of medications to companion animals: Palatability considerations. Adv Drug Deliv Rev. 2004;56:1399-1413.